EyePoint Pharmaceuticals: Q1 Earnings Insights

Comments
Loading...

EyePoint Pharmaceuticals EYPT reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

EyePoint Pharmaceuticals beat estimated earnings by 17.65%, reporting an EPS of $-0.56 versus an estimate of $-0.68.

Revenue was down $1.61 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 12.8% increase in the share price the next day.

Here's a look at EyePoint Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.61 -0.70 -0.52 -0.58
EPS Actual -0.61 -0.49 -0.52 -0.56
Revenue Estimate 10.40M 10.64M 10.87M 9.89M
Revenue Actual 10.53M 10.01M 11.56M 9.29M

To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

EYPT Logo
EYPTEyePoint Pharmaceuticals Inc
$7.35-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum11.09
Growth19.37
Quality-
Value52.67
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: